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Abstract
Over the recent years, next generation sequencing and microarray technologies have revo-
lutionized scientific research with their applications to high-throughput analysis of biological
systems. Isolation of high quantities of pure, intact, double stranded, highly concentrated,
not contaminated genomic DNA is prerequisite for successful and reliable large scale
genotyping analysis. High quantities of pure DNA are also required for the creation of
DNA-banks. In the present study, eleven different DNA extraction procedures, including
phenol-chloroform, silica and magnetic beads based extractions, were examined to
ascertain their relative effectiveness for extracting DNA from ovine blood samples. The
quality and quantity of the differentially extracted DNA was subsequently assessed by
spectrophotometric measurements, Qubit measurements, real-time PCR amplifications
and gel electrophoresis. Processing time, intensity of labor and cost for each method were
also evaluated. Results revealed significant differences among the eleven procedures and
only four of the methods yielded satisfactory outputs. These four methods, comprising three
modified silica based commercial kits (Modified Blood, Modified Tissue, Modified Dx kits)
and an in-house developed magnetic beads based protocol, were most appropriate for
extracting high quality and quantity DNA suitable for large-scale microarray genotyping
and also for long-term DNA storage as demonstrated by their successful application to
600 individuals.
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Introduction
The successful completion of the Human Genome Project and the achievement of similar goals
in other species have generated a huge amount of freely available information about the geno-
mic sequence of different organisms, opening the door to a post-genomic era where new chal-
lenges arise [1,2]. This new era is also characterized by the development of new technologies
which enable the study of thousands of genes and/or molecular markers at once. Such a tech-
nology is based on DNAmicroarrays, which is a multiplex technique used for rapid, large-scale
genotyping. This technique has fast become a standard approach in molecular biology research
and clinical diagnostics [3]. Microarrays have already been successfully applied in as diverse
scientific studies as cell biology, molecular microbiology, cancer genetics, genetic and metabolic
disorders, infectious diseases, drug discovery, host-pathogen interaction, population genetics,
linkage analysis, genetic improvement of livestock species, evolutionary biology, detection of
food-borne pathogens, stress responses, forensic analysis and toxicological research [3–9].
In the last few years, further enormous advances in genotyping technology have been taking
place with the development of the next generation sequencing (NGS) technologies. Whole ge-
nome sequencing provides information on a genome that is orders of magnitude larger than
that provided by DNA microarrays [10]. To date, these technologies have been applied in a
variety of contexts, including whole genome sequencing, de novo genome sequencing, exome
sequencing, targeted resequencing, cancer cell sequencing, de novo transcriptome sequencing,
RNA sequencing, small RNA sequencing, metagenomic sequencing and microbial strain
screening, among others [11–18] (http://www.beckmangenomics.com/genomic_services/next_
generation_sequencing/). Although NGS platforms are improving at a very quick rate, thereby
reducing costs by a factor of two to three each year, the cost is still too high for routine large-
scale sequencing of whole genomes for scientific research [19]. At this point, next generation
platforms are usually used as complementary to microarray analysis.
Microarray technology has been improved significantly in that period, in terms of dimin-
ished cost and sample requirement, and has yielded increased data density and quality [20].
However, it still remains a complex process that is prone to technical difficulties if reagents and
input material are not of suitable quality [21,22]. The first crucial step for microarray analysis
is considered to be DNA extraction and quality control of the extracted nucleic acids. Whole-
genome microarray analysis continues to require an input DNAmass that is at least 100 times
larger than that required for simple PCR testing and requires very pure DNA that is double
stranded with a length span at least 5 times longer than required for most PCR reactions [23].
Usually, a DNA quantity of 2.5 to 3.0 mg is necessary depending on the array size and platform
used (http://www.ark-genomics.org/news/edinburgh-genomics). However, when other panels
and techniques are used for whole genome genotyping, like KASP genotyping, a higher
quantity of DNA, up to 6.0 mg, is required (http://www.lgcgenomics.com/genotyping/kasp-
genotyping-chemistry/genotyping-panels). Similarly, in the case of NGS, DNA quantity re-
quirements differ depending on the genotyping aim and the platform used. For whole genome
de novo sequencing, which is used to sequence uncharacterized genomes where there is no ref-
erence sequence available or known genomes where significant structural variation is expected
like in cancer cells, a very high DNA quantity is required, usually from 30 to 60 mg depending
on the platform. For whole genome sequencing, usually a quantity above 10 mg, ideally 20 mg
DNA is desirable, while for targeted resequencing of custom regions of interest a lower DNA
quantity of about 3 to 6 mg is used [12] (http://genepool.bio.ed.ac.uk/illumina/samples.html).
A minimum concentration of 50 ng/ml is also necessary in both microarray and NGS analysis.
Picogreen assay with Qubit platform is considered to be the method of choice for DNA quanti-
fication. Implementation of quantification methods other than Picogreen may lead genotyping
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companies to ask for more concentrated and higher amounts of DNA for the analysis (http://
genepool.bio.ed.ac.uk/illumina/samples.html). A gel photo documenting high quality DNA is
required to accompany the samples, as well. Although the different NGS and microarray
platforms have specific requirements regarding DNA quantity, purity and integrity in order to
achieve reliable genotyping data, no specific guidance on the protocol of choice is given by the
genotyping centers. The need for robust methods that produce a representative, non-biased
source of nucleic acid material from the genome under investigation is acknowledged [12].
Another important aspect regarding DNA extraction protocols and advanced genotyping
analysis is the suitability of the extracts for long term DNA-banking. Usually DNA extracts
have to be stored until all samples are collected, which differs among the studies, and until the
genotyping centers have capacity available. Moreover, there is an increased interest in the crea-
tion of DNA banks since sample collection and DNA extraction are laborious, expensive and
time consuming procedures. Storage tests carried out by the DNA Bank Network revealed that
high purity of extracted DNA must be ensured, since secondary compounds and heavy metal
ions can result in highly reactive intermediates causing all sorts of DNA damage [24,25].
Although, the selection of an appropriate DNA extraction method plays a pivotal role in the
success of genome-wide studies and long term DNA-banking, there are no established standard
operating procedures for genomic DNA extraction. Moreover, there are no published reports on
simultaneous comparisons of the efficiency of different genomic DNA extraction procedures for
microarray analysis or NGS applications, and only a few studies in the literature that compare
different extraction protocols for microbial DNA suitable for microarrays analysis [21,26–29].
The objective of this work was to evaluate eleven different methods for extraction of genomic
DNA from ovine blood samples in terms of DNA quantity, concentration, purity, integrity and
real-time PCR suitability, as well as utility and applicability for subsequent DNAmicroarray
genotyping and long–term storage.
Materials and Methods
Resource Population and Sample Collection
At first, 11 blood samples were taken from each of 16 ewes of the Chios dairy breed raised in
an experimental flock. These samples were used to evaluate the DNA extraction methods de-
scribed next. Peripheral blood samples were collected in 9 ml K2EDTA Vacutainer blood col-
lection tubes (BD diagnostics) by jugular venepuncture. These samples were inverted to mix
and prevent clotting and immediately placed in isothermic boxes and transferred to the labora-
tory. Individual blood samples from the same animal where mixed together and then divided
again in order for each blood sample to contain the same amount of leucocytes. At the end of
the procedure, all 16 animals had DNA extracted with each one of 11 DNA extraction methods
described in detail in the next section.
Three of the DNA extraction methods (Nucleospin Blood, Nucleospin Blood L, Nucleospin
Blood XL, Macherey-Nagel, Duren, Germany) used whole blood as source of genomic DNA
while the rest of them used buffy coat (Table 1). In the latter cases, buffy coat was prepared by
spinning whole blood at 3,000 g for 10 min in an Eppendorf (5415R) centrifuge (Hamburg,
Germany) at room temperature to separate the blood into its plasma, leukocyte and erythrocyte
fractions. The buffy coat was removed and dispersed in 700 ml of red cell lysis buffer (25 mM
NaHCO3, 0.3 M NH4Cl, 5 mM EDTA). A second centrifugation at 3,000 g for 10 min at room
temperature followed. The liquid was discarded and the leucocyte pellet was dispersed in differ-
ent buffers depending on the DNA extraction method followed.
In addition, 600 blood samples were collected from as many Chios ewes (different from the
16 animals mentioned previously) raised in five different flocks in the northern part of Greece.
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These samples were used for a large-scale application and further evaluation of the DNA ex-
traction methods of choice.
During sampling animals were handled by qualified veterinarians. Permission to qualified
veterinarians to perform blood sampling was established by the National (Greek) Legislature
for the Veterinary Profession, No. 344/29-12-2000. The study was approved by the Ethics and
Research Committee of the Faculty of Veterinary Medicine, Aristotle University of Thessaloniki,
Greece, which monitors and approves all experimental protocol carried out in the flock in the
experimental farm. This farm is a model commercial farm equipped with modern facilities.
Housing is designed to provide optimal welfare conditions for raising sheep in terms of space
availability and ventilation in the sheep shed. Permit for access and use of the experimental flock
was obtained from the Ethics and Research Committee of the Faculty of Veterinary Medicine,
Aristotle University of Thessaloniki, Greece. Permits for the commercial farms were granted by
the farm owners, who were members of the Chios Sheep Breeders’ Cooperative “Macedonia”.
The study did not involve endangered or protected species. The location of the farms was in
the Northern Greece (latitude 41oN, 23oE).
DNA Extraction Methods
Eleven different DNA extraction methods were evaluated using whole blood and buffy coat ob-
tained from the 16 ewes. All methods are listed in Table 1.
Three commercially available kits, Nucleospin Blood, Nucleospin Blood L, Nucleospin
Blood XL (Macherey-Nagel, Duren, Germany) were tested. The amount of whole blood used
as source of genomic DNA was 200 ml, 2 ml and 10 ml, respectively. DNA extraction was per-
formed according to the manufacturer’s instructions.
Nucleospin Blood-Buffy Coat and Nucleospin Tissue-Buffy Coat methods (Table 1) were
direct applications of extraction kits Nucleospin Blood and Nucleospin Tissue (Macherey-
Nagel, Duren, Germany), respectively, with a buffy coat of 9 ml blood being used instead of
200 ml whole blood. The leucocytes were re-suspended in 200 ml PBS and extraction was per-
formed according to the manufacturer’s instructions. At the end, the purified DNA was eluted
from the nucleospin column in a 150 ml elution buffer (EB).
Table 1. Eleven DNA extraction methods and descriptive statistics of the measurements used to evaluate the respective quality of DNA
extracted.
Method* OD 260/280 OD 260/230 C. coli Ct values
Median Range SD Median Range SD Median Range SD
Nucleospin Blood (200 μl WB, SC) 1.76 1.6–1.8 0.68 1.83 1.0–2.1 0.30 29.65 28.8–30.4 0.55
Nucleospin Blood L(2 ml WB, SC) 1.69 1.2–1.8 0.21 1.30 1.1–1.9 0.53 29.64 28.7–30.5 0.63
Nucleospin Blood XL (10 ml WB, SC) 1.70 1.3–1.8 0.12 1.35 0.9–1.8 0.32 29.68 28.6–30.6 0.62
Nucleospin Blood-Buffy Coat (9 ml BC, SC) 1.94 1.8–2.0 0.06 2.14 1.9–2.2 0.11 29.68 28.7–30.2 0.57
Nucleospin Tissue-Buffy Coat (9 ml BC, SC) 1.80 1.7–1.9 0.07 2.13 1.6–2.5 0.30 29.50 28.7–30.2 0.60
Modified Blood (9 ml BC, SC) 1.87 1.7–1.9 0.05 2.30 1.9–2.2 0.19 29.57 28.7–30.2 0.56
Modified Tissue (9 ml BC, SC) 1.86 1.7–2.0 0.07 2.13 1.6–2.4 0.30 28.83 29.5–30.3 0.56
Modified Dx (9 ml BC, SC) 1.82 1.6–1.9 0.08 2.11 1.8–2.3 0.15 30.20 28.4–30.5 0.72
Phenol – Chloroform (9ml BC, FC) 1.67 1.5–1.8 0.11 2.04 1.3–2.3 0.28 30.20 26.7–32.7 1.39
Charge-Switch (4.5 ml BC, B) 1.47 1.3–1.7 0.12 0.75 0.6–1.2 0.14 30.12 28.7–30.4 0.62
In-house (4.5 ml BC, B) 1.72 1.6–1.9 0.09 1.88 1.7–2.1 0.13 30.07 28.8–30.3 0.55
* Volume, DNA source and technology used are in parentheses; WB = whole blood, BC = buffy coat, SC = silica column, B = beads, FC = Phenol-
Chloroform extraction
doi:10.1371/journal.pone.0115960.t001
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In Modified Blood, Modified Tissue and Modified DX methods (Table 1), Nucleospin
Blood, Nucleospin Tissue and Nucleospin Blood Dx commercial kits (Macherey-Nagel, Duren,
Germany), respectively, were modified in order to increase DNA recovery and purity. The key
modifications introduced to the commercial kits consisted of sample pretreatment to eliminate
PCR inhibitors and thus increase DNA yield. Specifically, buffy coat was treated with increased
volumes of lysis buffers and proteinase K. In addition, duration of incubation with proteinase
K was increased to eliminate the amounts of cell debris, proteins and lipids. A chloroform step
to remove lipids and other insoluble solids was added as well. More specifically, buffy coat of 9
ml blood was used as a source of DNA. Leucocyte cells were re-suspended in 200 ml PBS. In-
creased volumes of proteinase K (37.5 ml instead of 25 ml) and lysis buffers (270 ml instead of
180 ml) from each kit were added, and the mixture was incubated first in 56°C for 1.5 hours
and then in 70°C for 15 min. Subsequently, 500 ml of chloroform were added and the mixture
was vigorously rotated for 20 min. After centrifugation at 16,000 g for 10 min at 4°C using an
Eppendorf (5415R) centrifuge, the aqueous phase was transferred to a tube containing 320 ml
of absolute ethanol. The mixture was then applied to nucleospin columns (different for each
kit) and DNA was absorbed onto the nucleospin silica gel membrane during one centrifugation
at 11,000 g for 1 min. The silica was washed once using 500 ml of a guanidine containing buffer
(BW) and then twice using 400 ml of an ethanol containing buffer (B5). The purified DNA was
eluted from the nucleospin column in a 200 ml elution buffer (EB).
Phenol-Chloroform method (Table 1) was a standard phenol-chloroform based extraction
protocol containing proteinase K [30]. Buffy coat of 9 ml blood was used. The only modifica-
tions to that protocol were the addition of two extra steps in the end of the protocol. Briefly,
after the suspension of DNA in the elution buffer, 2 ml RNAse A (5 mg/ml Invitrogen,
Carlsband, CA) were added to digest the remaining RNA and the elution was extracted first
with 200 ml chloroform and afterwards with 200 ml PEG/NaCl (PEG 20%, NaCl 2.5M). The
aqueous phase was transferred and the DNA was precipitated at room temperature after the
addition of 0.5 ml of 75% ethanol. By a final centrifugation the DNA pellet was dried and
re-suspended in 50 ml DPCW and incubated overnight in 4°C.
Another commercially available kit, the ChargeSwitch gDNA Tissue Mini (Invitrogen,
Carlsbad, CA), was also tested (Table 1). Buffy coat of 4.5 ml blood was used as a source of geno-
mic DNA. The DNA extraction was performed according to the manufacturer’s instructions.
The last method (Table 1) was an In-house developed protocol based on the lysing and nu-
clease-inactivating properties of two chaotropic agents, guanidinium hydrochloride (GuHCl)
and guanidinium thiocyanate (GuaSCN), together with the use of magnetic beads as the affini-
ty matrix. Different blood quantities were tested for buffy coat preparation and the quantity of
4.5 ml was chosen because it resulted in better DNA quantity and quality. In brief, leucocyte
cell pellet, coming from buffy coat, was resuspended in 250 ml PBS. Volumes of 250 ml lysis
buffer A (50mM Tris- HCl, 50mM EDTA, 4M GuHCl, 10 mM CaCl2, 1% v/v Triton X-100,
2% N-Lauroyl-Sarcosine, pH = 7.5) and 50 ml of proteinase K (22.4 mg/ml, MERK) were
added and the lysate was homogenized and incubated in 56°C for 1.5 h. A volume of 600 ml
of lysis buffer B (50 mM Tris-HCl, 25 mM EDTA, 6 M GuaSCN, 3% v/v Triton X-100, 6%
N-Lauroyl-Sarcosine, pH = 5.5) was added and the suspension was incubated at 70°C for
10 min. 500 ml of absolute isopropanol was added to the lysate. Then, 40 ml (50 mg/ml) of
magnetic silica particles, PMSi-H1.0–5 (Kisker Biotech GmbH, Steinfurt, Germany) were
added for DNA binding. The samples were homogenized and placed to MagnaRack (Invitrogen,
Carlsbad, CA). Subsequently, the magnetic beads were washed three times starting with 700 ml
wash buffer A (25 mM Tris-HCl, 4 M GuHCl, 30% v/v absolute isopropanol, pH 6.6), then
twice with 500 ml wash buffer B (10 mMTris-HCl, 100 mMNaCl, 80% v/v absolute isopropanol,
pH 6.6). As a final step, the magnetic beads were transferred to new 2 ml tubes and incubated
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at room temperature for 10 min with open caps. DNA was recovered in 1200 ml TE buffer se-
quentially, each time using 600 ml TE buffer (10 mM Tris-HCl, pH = 9) preheated in 65°C.
Evaluation of DNA Extraction
Spectrophotometer and Qubit Measurements
Purity of DNA extracted with each method was assessed using an Eppendorf Biophotometer.
The ratio of absorbance at 260 nm and 280 nm was used to assess protein contamination while
the ratio of absorbance at 260 nm and 230 nm was calculated to assess guanidine contamina-
tion. Both spectrophotometric measurements constituted criteria for DNA quality assessment
with higher values associated with better DNA purity.
Quantity of DNA extracted by the different methods was assessed using Qubit 2.0 fluorometer
(Invitrogen, Life technologies). The Qubit fluorometer calculates concentration based on the
fluorescence of a dye which binds to double stranded DNA (dsDNA). The Qubit fluorometer
picks up this fluorescence signal and converts it into a DNA concentration measurement using
DNA standards of known concentration. Qubit dsDNA BR Assay Kit was used for the DNA
quantification.
Based on DNA concentration derived from the Qubit measurements and the volume of the
DNA extract, total DNA yield was calculated with a simple multiplication.
Gel Electrophoresis
The integrity of DNA extracted by each method was assessed by gel electrophoresis [31,32].
Specifically, 1 ml of each DNA extract was analysed in a 1.5% agarose gel containing 0.5%
ethidium bromide and was visualized by U.V. illumination.
Real-time PCR
A real-time PCR targeting the ovine prion protein gene (PRNP) was used to assess presence of
amplifiable DNA in extracts of blood samples. The set of primers (amplifying a 168 bp PRNP
genomic region), amplification reaction set up and thermo-cycling conditions described in a pre-
vious study [30] were applied here, too. Ct values were used to assess the amount of amplifiable
DNA obtained. Smaller Ct values are desirable in this regard.
A second real-time PCR protocol was applied to assess the ability of the different genomic
DNA extraction protocols to remove PCR inhibitors from blood samples [26,28]. The presence
of PCR inhibitors in the genomic DNA extracts was tested by spiking 1000 bacterial genomic
copies DNA (Campylobacter coli C. coli, strain ATCC 43478) into 100 ng and 1000 ng of sheep
DNA extracts, respectively, followed by real-time PCR amplification of hydroxymethyltransferase
gene (glyA). Real-time PCR amplifications [33] were performed using a Biorad CFX96 Real-time
System.
All samples were run in triplicates while in every PCR trial, three controls containing only
the C. coli DNA spike (without sheep DNA), were included. Ct values obtained in the process
were used to assess the presence of PCR inhibitors. Specifically, the resultant inhibition of the
amplification was assessed in comparison to the non-spiked control.
Statistical Analysis
The 11 different DNA extraction methods were assessed with the model: Yij = m + pi + sj + eij,
where Yij = DNA score by evaluation criterion for the i
th extraction method and jth animal,
m = overall mean, pi = effect of i
th DNA extraction method (i = 1–11), sj = effect of the j
th animal
(j = 1–16) and eij = random residual.
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Each DNA evaluation criterion [two spectrophotometric measurements (O.D. 260/280, O.
D. 260/230), DNA concentration, total DNA yield, and two real-time PCR results (Ct PRNP,
Ct glyA)] was assessed in a separate analysis.
A Bonferroni adjustment for multiple testing was implemented in the comparison of differ-
ent DNA extraction methods for each evaluation criterion. Statistical significance level was set
at 0.05. All analyses were performed using the statistical package ASREML [34].
Large-Scale Application, Long-Term DNA Storage and Microarray
Genotyping
Based on the results of the statistical analysis, the modified methods (Modified Blood, Modified
Tissue, Modified Dx kits) and the In-house developed protocol were selected to be further
tested in order to assess their robustness and large-scale applicability for long-term storage
and microarray analysis. Specifically, genomic DNA was extracted from 600 Chios ewes,
using Modified Blood for 150 of them, Modified Tissue for another 150, Modified Dx for
200 and the In-house protocol for the remaining 100 ewes. The quantity and the purity of
DNA extracts were assessed using a spectrophotometer (Eppedorf Biophotometer) and the
samples were stored for 3 years at −20°C. At the end of this period, quality (O.D. 260/280 and
O.D. 260/230) of the DNA was measured using a Nanodrop ND-1000 spectral photometer
(Nanodrop Technologies, Wilmington, DE, USA) and quantity was measured using Qubit 2.0
fluorometer and Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen, Life technologies).
Integrity of DNA was tested by gel electrophoresis (1% agarose gel). The same model as above
was used to assess differences in the large-scale performance of the four extraction protocols.
Since there was only one observation per animal, the ewe effect was not included in the model
in these analyses.
Subsequently, DNA extracts from all samples were diluted appropriately so the same quan-
tity (2.5 mg) of DNA per sample would be available for microarray genotyping. Genotyping,
which took place three years after the extraction of the DNA, was based on a customized 960
SNP whole-genome array (Illumina) including polymorphisms that had been previously found
to have a significant effect on mastitis traits in three other breeds in three different countries
[35,36].
The four extraction methods were then evaluated further based on the genotyping quality at
each SNP locus assessed by the corresponding call rate. Call rate is defined as the proportion of
genotype calls for a SNP assigned a genotype other than unknown [37]. Values range from 0 to
100% and higher values are desirable. Two genotyping quality measurements were used as cri-
teria for the evaluation of the DNA extraction methods: average call rates per animal across all
SNP and individual SNP call rates. Each genotyping quality criterion was assessed separately
with a model including the effects of overall mean, DNA extraction method (1–4) and random
residual. In the analysis of individual SNP call rates, the random effect of ewe was also
included.
As before, a Bonferroni adjustment for multiple testing was implemented. Statistical
significance level was set at 0.05. All analyses were performed using the statistical package
ASREML.
Results and Discussion
Method Comparison
Descriptive statistics of all 11 methods for the two spectrophotometric measurements, the glyA
real-time PCR results, the DNA concentration, the total DNA yield and the PRNP real-time
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PCR results based on application to 16 ewes are summarized in Tables 1 and 2, respectively.
Marginal means for each extraction protocol and comparisons between protocols derived from
the statistical analyses are shown in Table 3.
Spectrophotometric measurements
According to the 260/280 nm absorbance ratio results, the Nucleospin Blood-Buffy Coat
protocol extracted the purest DNA, followed by Modified Tissue, Modified Blood and
Table 2. Descriptive statistics of the measurements used to evaluate quantity of DNA extracted by 11 different methods.
Method DNA concentration (ng/μl) Total DNA yield1 (μg) PRNP Ct values
Median Range SD Median Range SD Median Range SD
Nucleospin Blood 55.6 17–102 19 5.56 1.7–10 2 24.7 23.0–27.4 1.2
Nucleospin Blood L 112 18–377 102 22.5 4–75 20 23.9 22.2–28.1 2.6
Nucleospin Blood XL 163 61–322 71 326 122–644 143 23.2 21.4–25.7 1.2
Nucleospin Blood Buffy Coat 64.1 24–119 32 12.8 3.72 6 23.2 21.8–26.3 1.4
Nucleospin Tissue Buffy Coat 49.2 20–131 37 7.38 3–19 5 24.5 22.9–27.5 1.3
Modified Blood 103 52–172 46 15.5 10–26 7 24.0 22.3–25.4 0.9
Modified Tissue 104 61–360 67 21.6 12–72 13 23.3 19.0–26.2 1.7
Modified Dx 231 61–768 185 46.2 12–153 37 23.1 21.9–24.7 0.8
Phenol—Chloroform 260 4–585 154 13 0.2–29 7 24.5 21.7–29.3 2.5
Charge-Switch 7.1 3–10 2 1.85 0.7–4 1 26.0 23.7–29.1 2.0
In-house 288 141–592 129 346 169–710 155 23.3 21.6–26.6 1.4
doi:10.1371/journal.pone.0115960.t002
Table 3. Statistical comparison of 11 genomic DNA extraction methods applied to 16 animals.
Method (total DNA volume (μl)
in parenthesis
OD 260/2801 OD 260/2301 Ccoli2 Ct values DNA
concentration1
(ng/μl)
Total DNA
yield1 (μg)
PRNP2 Ct values
Nucleospin Blood (100) 1.74 (0.02)a, d 1.79 (0.07)a 29.61 (0.17)a 56 (22.5)a, d 5.6 (15.9)a 24.95 (0.41)a
Nucleospin Blood L (200) 1.63 (0.02)e 1.31 (0.07)d 29.60 (0.17)a 118 (22.5)a, d, c 23.6 (15.9)a, b 24.82 (0.41)a
Nucleospin Blood XL (2,000) 1.68 (0.02)a, d, e 1.30 (0.07)d 29.66 (0.17)a 162 (22.5)c 324.3 (15.9)c 23.42 (0.41)c
Nucleospin Blood-Buffy
Coat (150)
1.94 (0.02)b 2.10 (0.07)a, b 29.60 (0.17)a 63 (22.5)a, d 12.6 (15.9)a, b 23.95 (0.41)a, c
Nucleospin Tissue-Buffy
Coat (150)
1.79 (0.02)d 2.10 (0.07)a, b 29.49 (0.17)a 59 (22.5)a, d 8.9 (15.9)a 24.77 (0.41)a, b
Modified Blood (200) 1.84 (0.02)a, b, d 2.18 (0.07)b 29.55 (0.17)a 93 (22.5)a, c, d 18. 8 (15.9)a, b 23.73 (0.42)b, c
Modified Tissue (200) 1.85 (0.02)a, b, d 2.14 (0.07)a, b 29.57 (0.17)a 120 (22.5)a, c, d 24.6 (16.4)a, b 23.23 (0.41)c
Modified Dx (200) 1.80 (0.03)a, b, d 2.08 (0.08)a, b 29.65 (0.18)a 289 (25.9)b 57.8 (18.4)b 22.95 (0.46)c
Phenol-Chloroform (50) 1.65 (0.03)a, e 1.98 (0.08)a, b 29.74 (0.18)a 258 (25.9)b 12.8 (18.4)a 24.69 (0.48)a
Charge-Switch (250) 1.49 (0.03)c 0.78 (0.08)c 29.64 (0.18)a 7.7 (25.9)a 1.8 (18.4)a 26.36 (0.46)d
In-house (1,200) 1.74 (0.03)a, d 1.87 (0.08)a, b 29.62 (0.18)a 302 (25.9)b 362.7 (18.4)c 23.32 (0.46)c
Two spectrophotometer measurements (OD260/280 and OD260/230 nm) and real-time PCR results of C. coli spiked samples (Ct values) used to assess
DNA purity and PCR inhibitors respectively. DNA concentration was assessed with qubit measurements and real-time PCR targeting the PRNP gene (Ct
values); results are marginal means with standard errors in parentheses.
1Higher values are desirable.
2Lower values are desirable.
a,b,c,d,e Comparison of values within each column; values with the same superscript are not statistically different (P>0.05) from each other but they differ
significantly (P<0.05) from values with different superscript.
doi:10.1371/journal.pone.0115960.t003
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Modified Dx protocols (Table 3). These protocols showed a 260/280 nm ratio above 1.8, which
is considered standard for pure DNA [26,30]. Moreover, Nucleospin Tissue-Buffy Coat, In-
house and Nucleospin Blood protocols showed values near the desirable limit of 1.8. Differ-
ences among these seven protocols were not significantly different from zero (P>0.05) but they
all led to significantly (P<0.05) purer DNA compared to Nucleospin Blood L and Charge
Switch gDNA Tissue Mini Kit.
According to 260/230 nm ratio results (Table 3), Modified Blood, Modified Tissue, Modi-
fied Dx, Nucleospin Blood-Buffy Coat and Nucleospin Tissue-Buffy Coat protocols were asso-
ciated with values above 2.0, which are the most desirable [30,38]. Phenol-Chloroform and In-
house protocols followed with values slightly lower than 2. Although differences among these
seven protocols were not significantly greater than zero (P>0.05), they all led to significantly
(P<0.05) purer DNA compared to Nucleospin Blood L, Nucleospin Blood XL and Charge
Switch Tissue Mini Kit protocols.
The two spectrophotometric measurements are frequently used for the evaluation of DNA
purity [39–41]. A low 260/280 nm ratio is indicative of contamination with proteins, which
could inhibit downstream applications and hamper DNA-banking [42]. A low 260/230 nm
ratio is indicative of contamination with phenol or guanidine carried over during the washing
steps of the silica columns or magnetic beads. Remaining organic compounds like phenol, gua-
nidine, salt or solvents are also considered inhibitors for downstream applications [28].
According to the two spectrophotometric ratios, Nucleospin Blood L, Nucleospin Blood XL
and Charge Switch Tissue Mini Kits did not extract pure DNA, suitable for NGS or microarray
analysis. In the case of Nucleospin Blood L and XL kits this result could be attributed to the
high volume of blood (2 and 10 ml, respectively) used for the extraction. All other methods
that used high volumes of blood (commercial kits, Phenol-Chloroform, In-house protocol) had
spectrophotometric measurements showing satisfactory purity levels. This improvement could
be attributed to the addition of a buffy coat step which was an additional purification step from
plasma proteins and erythrocytes. Therefore, isolated leucocytes seem to be more appropriate
source of DNA compared to whole blood when high quantities of DNA recovery are required.
However, in the case of Charge Switch Tissue Mini Kit, the buffy coat step was not adequate to
extract pure DNA. The low purity of DNA in that case could be attributed to the fact that foam
was formed during the washing steps. In the In-house developed protocol, foam formation
during the washing steps was also a problem when ethanol was used in the washing buffers.
The problem was solved by isopropanol instead of ethanol. Isopropanol was able to disperse
and wash the magnetic beads more efficiently without the formation of foam.
DNA concentration and total DNA yield
Concentration and total yield of extracted DNA were assessed using the Qubit Platform. Mea-
surements revealed that the In-house protocol extracted the most concentrated DNA, followed
by the Modified Dx and the Phenol-Chloroform protocols (Table 3). The differences among
these three protocols regarding DNA concentration were not significantly greater than zero
(P>0.05). Nevertheless, it should be mentioned that in the case of Phenol-Chloroform proto-
col, two extracts out of the sixteen had DNA concentration lower than 50 ng/ml, which is con-
sidered to be the minimum amount suitable for complex genotyping studies (http://genepool.
bio.ed.ac.uk/illumina/samples.html). Moreover, these three protocols extracted significantly
(P<0.05) more concentrated DNA compared to all other protocols used in the present study.
Charge Switch Tissue Mini kit extracted DNA with an average concentration lower than 50 ng/ml
while Nucleospin Blood, Nucleospin Blood-Buffy Coat and Nucleospin Tissue-Buffy Coat
methods yielded average concentrations just over this threshold. However, many of the samples
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from these three methods had concentrations lower than 50 ng/ml. The introduction of modifica-
tions to Blood and Tissue kits increased considerably (almost doubled) the concentration of
DNA extracted from buffy coat and always yielded DNAwith concentration above the desirable
threshold (Table 2). These modifications reduced the impurities and lowered the viscosity of the
aqueous solution added to the silica columns. In the case of unmodified protocols, the gelatinous
mucus created during the lysis step, which contained DNA among others, had to be removed
since it could not get through silica membranes and thus, a DNA quantity was inevitably lost.
The same problem was also present when magnetic beads were used. In order to overcome this
problem, we used less blood (4.5 instead of 9 ml) in the preparation of buffy coat for the In-house
protocol. In addition, lysis buffers in the In-house protocol contained detergents, which resulted
in the dissolution of the gelatinous mucus created during the lysis step and thus high quantity of
DNA was able to bind to the magnetic beads. In the case of Charge Switch kit, where no effort to
optimize the protocol was performed, it seems that most of DNA present in the gelatinous mucus
was not able to be absorbed on the magnetic beads.
Total DNA yield extracted with each protocol was calculated by multiplying DNA concen-
tration measured with the Qubit platform with final elution volume (Table 2). According to
these calculations, the In-house protocol extracted the highest DNA yield followed by
Nucleospin Blood XL kit (Table 2). Interestingly, in the aforementioned protocols, a large
extraction volume (1,200 ml and 2,000 ml, respectively) was used compared to the other proto-
cols (50–250 ml). Differences between these two kits were not significant but both protocols
performed significantly better compared to all the others (Table 3). Among the other protocols,
Modified Dx kit recovered the highest DNA yield. Nucleospin Blood and Charge Switch Tissue
Mini kits extracted the lowest DNA quantity. For Nucleospin Blood, this was due to the low
initial blood volume (200 ml) used for the extraction, while for Charge Switch Tissue Mini kits,
probably due to the inability of lysis buffer and proteinase K to dissolve the gelatinous mucus
formed by leucocyte pellet.
The Qubit assay is the method of choice for accurate estimation of DNA quantity for NGS
or microarray applications (http://genepool.bio.ed.ac.uk/illumina/samples.html). Qubit plat-
form provides a rapid, sensitive and accurate method for dsDNA quantification with minimal
interference from RNA, protein, single stranded DNA (primers) or other common contami-
nants that affect UV absorbance [43]. According to Qubit measurements, the In-house,
Nucleospin Blood XL and Modified DX protocols extracted sufficient DNA quantity for use in
large-scale genotyping applications, even for de Novo sequencing, and for the creation of DNA
banks for future use at the same time (Table 3). Moreover, Modified Tissue, Modified Blood,
Nucleospin Blood-Buffy Coat, Nucleospin Blood L and Phenol-Chloroform protocols recov-
ered adequate DNA quantity for NGS applications (Table 3). Nucleospin Tissue-Buffy Coat
and Nucleospin Blood protocols recovered enough DNA for smaller scale NGS applications
like directed or targeted re-sequencing and for microarray analysis (Table 3).
Real-time PCR
Two real-time PCR analyses, one targeting the ovine PRNP gene and the other the C. coli glyA
gene, were conducted in order to evaluate the presence of amplifiable DNA and asses PCR in-
hibitors in the extracts spiked with C. coli, respectively. The PRNP gene is present in the sheep
genome and is responsible for controlling resistance to Transmissible Spongiform Encephalop-
athy in sheep. C. coli glyA is a single copy gene which is a known target for the reliable identifi-
cation and quantification of C. coli in complex samples.
Marginal means for Ct PRNP values obtained by each extraction protocol are shown at
Table 3. Lower Ct values are desirable since they are associated with larger amounts of
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amplifiable DNA. The Modified Dx, Modified Tissue and the In-house protocols gave the
lowest mean Ct values, followed by Nucleospin Blood XL and Modified Blood protocols. The
differences among these five protocols were not statistically significant (P>0.05). However,
they were statistically better (P<0.05) when compared to Nucleospin Blood, Nucleospin Blood
L, Nucleospin Tissue-Buffy Coat and Phenol-Chloroform protocols. Moreover, all the proto-
cols performed significantly (P<0.05) better compared to Charge Switch gDNA Tissue Mini
kit. In addition, two samples extracted with the Phenol-Chloroform protocol had unexpectedly
high Ct values as could be seen by the high standard deviation and the range of values mea-
sured for this protocol (Table 1). The OD measurements for these two samples were close to
the average for this protocol. Furthermore, Qubit measurements showed the existence of high
DNA quantity (267 ng/ml) in one of these two samples. No amplification was detected in the
non-template controls.
The real-time protocol targeting the gly-A gene of Campylobacter coli, showed an amplifica-
tion efficiency of 99.9%. Marginal means for Ct values obtained after the addition of spiked
genomic DNA are shown at Table 3. According to these results there was no statistically signifi-
cant difference in the performance of the 11 DNA extraction protocols and the controls con-
taining only the C. coli DNA spike, indicating efficient removal of PCR inhibitors. However, in
the case of Phenol-Chloroform protocol, one sample showed an unexpectedly high Ct-value
(Fig. 1), and another a very low fluorescence plateau; both samples had poor real-time PCR
performance for the amplification of the PRNP gene. The first of these two samples was the
one with the high DNA quantity, according to Qubit measurements. Furthermore, even though
the OD ratios for this sample were not indicative of low purity DNA (OD 260/280 = 1.74 and
OD 260/230 = 2.05), the real-time PCR results revealed the presence of PCR inhibitors.
In recent years, real-time PCR has become a reliable tool for assessing DNA quantity and
quality for downstream applications since many of the large scale genotyping protocols include
PCR based amplification steps [44–48]. The reason is that Ct values can assess PCR inhibition
and utility of the extracted sample for molecular analysis. PCR analyses can be inhibited by
Figure 1. Real-time PCR amplification plot of the gly-A gene, fromCampylobacter coli spiked extracted samples from sheep and the controls
containing only theCampylobacter coliDNA spike.Results from one sample with higher Ct value, extracted with the Phenol-Chloroform protocol is also
shown indicating the presence of inhibitors.
doi:10.1371/journal.pone.0115960.g001
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compounds typically present in blood and co-extracted with the DNA. Therefore, we tested the
DNA extracted with the 11 methods for the presence of PCR-inhibitors by using C. coli DNA
spikes as an external control. None of the extracts caused a detectable inhibition, since no sta-
tistical significant differences were observed among the Ct values obtained when only spike
DNA or spike and genomic sheep DNA (100 ng or 1000 ng), extracted with each one of the
11 methods, were present in the assay. The only exception was Phenol-Chloroform protocol
(two samples), rendering it unsuitable for large-scale downstream applications.
Gel Electrophoresis
Integrity of the extracted DNA was assessed by agarose gel electrophoresis (Fig. 2). Gel electro-
phoresis revealed that high-molecular-weight non-degraded genomic DNA was obtained with
all methods.
Figure 2. Representative results from gel electrophoresis analysis of genomic DNA from two different ovine blood samples extracted by eleven
methods. Charge Switch gDNAMini Tissue (lanes 1, 2), Nucleospin Blood (lanes 3, 4), Nucleospin Blood-Buffy Coat (lanes 5, 6), Modified Blood (lanes 7,
8), Nucleospin Tissue-Buffy Coat (lanes 9, 10), Modified Tissue (lanes 11, 12), Modified Dx (lanes 13, 14), Nucleospin Blood XL (lanes 15, 16), Phenol-
Chloroform (lanes 17, 18), In-house (lanes 19, 20), Nucleospin Blood L (lanes 21, 22), M molecular weight marker l DNA/Hind III digest.
doi:10.1371/journal.pone.0115960.g002
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Time, Labor and Cost Analysis
Comparison of the 11 protocols for labor intensity, throughput time and material cost per sam-
ple is reported in Table 4. The most rapid extraction method was the Nucleospin Blood kit
while the most time-consuming was the Phenol-Chloroform protocol. The other commercial
kits, modified or not, and the In-house developed protocol had intermediate time require-
ments. However, most of the required time involved no hands-on activities (e.g. longer in-
cubation time with proteinase K). On the other hand, Phenol-Chloroform protocol was the
cheapest, followed by the In-house developed and the Nucleospin Blood kit. The Charge Switch
gDNA Tissue Mini kits, Nucleospin Blood L and Nucleospin Blood XL had an increased cost
per sample by a factor of two, three and six, respectively, compared to the In-house protocol or
the Nucleospin Blood kit. Moreover, the Modified protocols, Blood, Tissue and Dx were only
slightly more expensive (0.2 euro per sample) compared to the unmodified ones. Nevertheless,
DNA extraction by Modified Dx and Tissue kits cost 1 euro more compared to the In-house
protocol. On the other hand, the In-house protocol required additional labor for the prepara-
tion of lysis and washing buffers. The Phenol-Chloroform protocol was the most technically
difficult to perform and also required the use of highly toxic phenol. All other methods had
almost the same labor intensity.
Overall Evaluation of the 11 methods
Considering all criteria described in the present study, the most robust protocols in terms of
DNA purity, concentration and total yield were the In-house and the modified versions of
the commercial kits (Modified Blood, Modified Tissue and Modified Dx protocols). Though
Nucleospin Blood, Nucleospin Blood-Buffy Coat and Nucleospin Tissue-Buffy Coat kits
extracted very pure DNA, the quantity of DNA recovered showed high variation among sam-
ples, as could be seen by the high standard deviation and the other descriptive statistics pre-
sented in Table 2. In addition, the total DNA yield was not sufficient enough. On the other
hand, Nucleospin Blood L and XL kits generated high yields of well concentrated intact DNA
but with a barely passable purity level, as could be also depicted by the high standard deviation
and the other descriptive statistics presented on Table 1. In addition, their high costs per
sample rendered them unsuitable for large-scale high throughput applications. The Phenol-
Chloroform protocol yielded highly concentrated DNA but in some cases DNA pellet was lost
and PCR inhibitors were present (Tables 1 and 2, Fig. 1). Moreover, this method was laborious
Table 4. Assessment of consumables cost per sample and process duration of 11 DNA extraction
methods.
Method Process duration (24 samples) Cost per sample (€)
Nucleospin Blood 1.15 h 2.8
Nucleospin Blood L 2.5 h 9.3
Nucleospin Blood XL 2.5 h 18.45
Nucleospin Blood-Buffy Coat 3 h 2.8
Nucleospin Tissue-Buffy Coat 3 h 3.8
Modified Blood 3.15 h 3.0
Modified Tissue 3.15 h 4.0
Modified DX 3.15 h 3.9
Phenol-Chloroform 3 days 2.5
Charge-Switch 2.5 h 6.4
In-house 2.5 h 2.8
doi:10.1371/journal.pone.0115960.t004
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and prone to technical variation due to the multi-step protocol, limiting its suitability for large-
scale studies. Finally, Charge Switch gDNA Tissue Mini kit had the poorest performance by all
criteria considered.
Large-Scale Application, Long-Term DNA Storage and Microarray
Genotyping
Based on the above overall evaluation, the Modified Blood, Tissue and Dx kits, and the In-
house protocol were selected to be used for DNA extraction of 600 ovine blood samples from
as many individual animals. These DNA extracts were tested for their suitability for long-term
storage and large-scale application. Gel electrophoresis of DNA extracts revealed specific clear
bands with adequate quantity, suitable for microarray analysis, after three years of storage
in −20°C (Fig. 3). No deterioration of DNA during the long storage was observed in any of
Figure 3. Representative results from gel electrophoresis analysis of genomic DNA from thirty different ovine blood samples extracted by four
methods.Modified Blood (lanes 1 to 8), Modified Tissue (lanes 9 to 15), Modified Dx (lanes16 to 22), In-house (lanes 23 to 30), M molecular weight marker
l DNA/Hind III digest.
doi:10.1371/journal.pone.0115960.g003
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these extracts, according to gel electrophoresis and Qubit measurements. The purity scores of
genomic DNA extracted by the Modified Blood, Tissue and Dx kits, and In-house protocols,
after three years of storage in −20°C, are summarized in Table 5. According to the Nanodrop
measurements all protocols extracted pure DNA, with OD 260/280 above 1.8 and OD 260/230
above 2.0. The variability among samples within the same protocol was very low as shown by
the low standard error estimates. Despite their statistical significance (P<0.05), differences
observed were not practically relevant since all four protocols clearly exceeded the threshold
values for DNA purity. Moreover, all four protocols extracted sufficient quantity of highly con-
centrated (above the 50 ng/ml threshold) DNA suitable for complex whole-genome genotyping
and DNA-banking from all 600 animals (Table 5). Specifically, Modified Dx protocol extracted
the most concentrated DNA, followed by the other two modified protocols (Modified Blood
and Tissue, Table 5). The three modified protocols had performed, on average, better regarding
the quantity of the DNA extracted compared to the results obtained from the initial evaluation,
based on the samples from the 16 ewes (Table 3). On the other hand the In-house protocol ex-
tracted less concentrated DNA compared to the modified protocols but it still recovered multi-
ple times more DNA, due to the high elution volume used (6 times higher compared to the
modified kits).
All extracts from the 4 methods proved to be equally suitable for microarray genotyping ap-
plications, based on the SNP call rates obtained. Table 6 summarizes results from the assess-
ment of genotyping quality by DNA extraction protocol. The marginal means of average and
individual SNP call rates per protocol were the same, showing that the variation of individual
SNP call rate within the same animal does not affect results. No statistical significant differ-
ences of the effect of the four extraction protocols on microarray genotyping were detected
(Table 6). These results were expected, since in all cases an adequate quantity of very pure and
well concentrated DNA was provided for the genotyping.
Table 5. Statistical comparison of four genomic DNA extraction methods based on spectrophotometer measurements (OD260/280nm, OD260/
230nm), DNA concentration and Total DNA yield; results are marginal means with standard errors in parentheses pertaining to 600 animals.
Method OD260/280 OD 260/230 DNA concentration(ng/ μl) Total DNA yield (μg)
Modified Blood 1.85 (0.01)a 2.19 (0.03)a 218 (14)a 43 (4.9)a
Modified Tissue 1.90 (0.01)b 2.40 (0.03)b 248 (14)a 49 (5.0) a
Modified Dx 1.89 (0.01)b 2.35 (0.02)b 310 (08)b 62 (2.9)a
In-house 1.85 (0.01)a 2.17 (0.04)a 207 (17)a 237 (6.2)b
a,b Comparison of values within each column; values with the same superscript are not statistically different (P>0.05) from each other but they differ
significantly (P<0.05) from values with different superscript.
doi:10.1371/journal.pone.0115960.t005
Table 6. Statistical comparison of four genomic DNA extraction methods applied to 600 animals,
based on microarray genotyping quality using average call rates across all SNP and individual SNP
call rates; marginal means with standard errors in parentheses.
Protocol Average Call Rates Individual SNP Call Rates
Modified Blood 0.775 (0.003)a 0.775 (0.0012)a
Modified Tissue 0.775 (0.003)a 0.775 (0.0013)a
Modified Dx 0.775 (0.003)a 0.775 (0.0008)a
In-house 0.777 (0.004)a 0.777 (0.0016)a
a Comparison of values within each column; values with the same superscript are not statistically different
(P>0.05) from each other.
doi:10.1371/journal.pone.0115960.t006
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Conclusions
Eleven extraction protocols were examined for effectiveness and efficiency in extracting and
purifying high quantity of genomic DNA from blood samples, suitable for large–scale complex
genotyping analysis and long-term DNA-banking. Four protocols, namely the In-house devel-
oped, and Modified Dx, Modified Tissue and Modified Blood appeared to be the best choices
to extract high yields of pure highly concentrated genomic DNA from buffy coat. Ovine blood
was used here as a study model but results may be generalized to humans or other mammalian
species.
In general, DNA requirements for microarray analysis can be met with the use of most of
the commercially available extraction kits. The most common problem when blood or tissue
extraction kits, like Nucleospin Blood, are applied is that in many cases less than required con-
centrated DNA is extracted (<50 ng/ml). Therefore, the whole extraction procedure should be
repeated. Moreover, according to the results of this study, simple commercial extraction kits
are not sufficient to extract the quantity of DNA needed for NGS applications or for the crea-
tion of DNA banks. For these cases, there are other available commercial kits, like Nucleospin
Blood L and XL. However, these kits which are quite expensive and, as shown in this study,
there is a shortcoming regarding the purity of the extract. The four proposed protocols, devel-
oped, evaluated and tested for microarrays genotyping can provide very high quantities of pure
DNA at a relatively low cost without being excessively laborious, rendering them appropriate
for whole-genome large-scale applications. The fact that these four protocols were based on
buffy coat instead of whole blood exemplifies the importance of the former in DNA extraction.
As NGS applications become routine in the near future, all the four proposed protocols
might provide very handy solutions. In addition, extracting quite higher DNA quantities than
needed for present applications and creating DNA banks can be very useful for follow-up or
parallel research projects. Visiting farms, collecting individual blood samples and extracting
DNA can be an expensive, demanding and laborious procedure which, if minimized, could
yield great savings in time and resources. In addition, extraction of high quality DNA of pre-
cious, difficult to collect samples, which can be archived for future reference, would be ex-
tremely useful.
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